Serrapeptase

DB13131InvestigationalProtein Based Therapies

Serrapeptase is a protease indicated in the treatment of post-surgical inflammation. Serrapeptase is a proteolytic enzyme preparation used concomitantly with an antibiotic in osteoarticular infections.

Mechanism: Pharmacologically active on Insulin
Curator reviewed
Also known as: Serratiopeptidase

Resolves to

Compound

UNIINL053ABE4JCAS95077-02-4

Clinical / RWD

RxNorm36434

Targets

P01308INS

What you can answer from here — as of August 27, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

3ContraindicationsEach with its own population and attribute set

19Marketed productsAcross 3 countries and 13 labellers

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Serrapeptase, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account